Form 8-K - Current report:
SEC Accession No. 0000950170-24-130262
Filing Date
2024-11-22
Accepted
2024-11-22 16:45:07
Documents
13
Period of Report
2024-11-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20241120.htm   iXBRL 8-K 40747
2 EX-5.1 hcwb-ex5_1.htm EX-5.1 30777
3 GRAPHIC img199955712_0.jpg GRAPHIC 44816
  Complete submission text file 0000950170-24-130262.txt   252239

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20241120.xsd EX-101.SCH 24849
15 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20241120_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 241490484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)